Global Alpha Thalassemia Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 99

Report ID: 1222

Alpha thalassemia causes due to deficiency or absence of alpha globin chains results in alpha thalassemia which is asymptomatic with general hematologic findings and gains silent carrier status. 
In 2018, the global Alpha Thalassemia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Alpha Thalassemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alpha Thalassemia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
GlaxoSmithKline
Novartis AG
Bellicum Pharmaceuticals
Acceleron Pharma
Johnson & Johnson
Merck & Co.
Gilead Sciences, Inc.
...

Market segment by Type, the product can be split into
Folic Acid
Deferasirox
Deferiprone
Hydroxyurea

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Alpha Thalassemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Alpha Thalassemia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Alpha Thalassemia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Folic Acid
1.4.3 Deferasirox
1.4.4 Deferiprone
1.4.5 Hydroxyurea
1.5 Market by Application
1.5.1 Global Alpha Thalassemia Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Alpha Thalassemia Treatment Market Size
2.2 Alpha Thalassemia Treatment Growth Trends by Regions
2.2.1 Alpha Thalassemia Treatment Market Size by Regions (2019-2025)
2.2.2 Alpha Thalassemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Alpha Thalassemia Treatment Market Size by by Players
3.1.1 Global Alpha Thalassemia Treatment Revenue by by Players (2014-2019)
3.1.2 Global Alpha Thalassemia Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Alpha Thalassemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Alpha Thalassemia Treatment Key Players Head office and Area Served
3.3 Key Players Alpha Thalassemia Treatment Product/Solution/Service
3.4 Date of Enter into Alpha Thalassemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Alpha Thalassemia Treatment Market Size by Type (2014-2019)
4.2 Global Alpha Thalassemia Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Alpha Thalassemia Treatment Market Size (2014-2019)
5.2 Alpha Thalassemia Treatment Key Players in North America
5.3 North America Alpha Thalassemia Treatment Market Size by Type
5.4 North America Alpha Thalassemia Treatment Market Size by Application

6 Europe
6.1 Europe Alpha Thalassemia Treatment Market Size (2014-2019)
6.2 Alpha Thalassemia Treatment Key Players in Europe
6.3 Europe Alpha Thalassemia Treatment Market Size by Type
6.4 Europe Alpha Thalassemia Treatment Market Size by Application

7 China
7.1 China Alpha Thalassemia Treatment Market Size (2014-2019)
7.2 Alpha Thalassemia Treatment Key Players in China
7.3 China Alpha Thalassemia Treatment Market Size by Type
7.4 China Alpha Thalassemia Treatment Market Size by Application

8 Japan
8.1 Japan Alpha Thalassemia Treatment Market Size (2014-2019)
8.2 Alpha Thalassemia Treatment Key Players in Japan
8.3 Japan Alpha Thalassemia Treatment Market Size by Type
8.4 Japan Alpha Thalassemia Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Alpha Thalassemia Treatment Market Size (2014-2019)
9.2 Alpha Thalassemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Alpha Thalassemia Treatment Market Size by Type
9.4 Southeast Asia Alpha Thalassemia Treatment Market Size by Application

10 India
10.1 India Alpha Thalassemia Treatment Market Size (2014-2019)
10.2 Alpha Thalassemia Treatment Key Players in India
10.3 India Alpha Thalassemia Treatment Market Size by Type
10.4 India Alpha Thalassemia Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Alpha Thalassemia Treatment Market Size (2014-2019)
11.2 Alpha Thalassemia Treatment Key Players in Central & South America
11.3 Central & South America Alpha Thalassemia Treatment Market Size by Type
11.4 Central & South America Alpha Thalassemia Treatment Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Alpha Thalassemia Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2014-2019))
12.1.5 GlaxoSmithKline Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Alpha Thalassemia Treatment Introduction
12.2.4 Novartis AG Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.2.5 Novartis AG Recent Development
12.3 Bellicum Pharmaceuticals
12.3.1 Bellicum Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Alpha Thalassemia Treatment Introduction
12.3.4 Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.3.5 Bellicum Pharmaceuticals Recent Development
12.4 Acceleron Pharma
12.4.1 Acceleron Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Alpha Thalassemia Treatment Introduction
12.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.4.5 Acceleron Pharma Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Alpha Thalassemia Treatment Introduction
12.5.4 Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Merck & Co.
12.6.1 Merck & Co. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Alpha Thalassemia Treatment Introduction
12.6.4 Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.6.5 Merck & Co. Recent Development
12.7 Gilead Sciences, Inc.
12.7.1 Gilead Sciences, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Alpha Thalassemia Treatment Introduction
12.7.4 Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2014-2019)
12.7.5 Gilead Sciences, Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details